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Pdx1 (pancreatic and duodenal homeobox 1), Ngn3 (neurogenin
3) and MafA (v-maf musculoaponeurotic ﬁbrosarcoma oncogene
family, protein A) have been reported to bring about the
transdifferentiation of pancreatic exocrine cells to beta (β) cells
in vivo. We have investigated the mechanism of this process
using a standard in vitro model of pancreatic exocrine cells,
the rat AR42j-B13 cell line. We constructed a new adenoviral
vector encoding all three genes, called Ad-PNM (adenoviral
Pdx1, Ngn3, MafA construct). When introduced into AR42j-
B13 cells, Ad-PNM caused a rapid change to a ﬂattened
morphology and a cessation of cell division. The expression
of exocrine markers is suppressed. Both insulin genes are up-
regulated as well as a number of transcription factors normally
characteristic of beta cells. At the chromatin level, histone tail
modiﬁcations of the Pdx1, Ins1 (insulin 1) and Ins2 (insulin 2)
gene promoters are shifted in a direction associated with gene
activity, and the level of DNA CpG methylation is reduced at
the Ins1 promoter. The transformed cells secrete insulin and
are capable of relieving diabetes in streptozotocin-treated NOD-
SCID (non-obese diabetic severe combined immunodeﬁciency)
mice. However the transformation is not complete. The cells lack
expression of several genes important for beta cell function and
theydonotshowglucose-sensitiveinsulinsecretion.Weconclude
that, for this exocrine cell model, although the transformation is
dramatic, the reprogramming is not complete and lacks critical
aspects of the beta cell phenotype.
Key words: AR42j-B13 cells, beta (β) cell, diabetes, direct
reprogramming, insulin.
INTRODUCTION
During embryogenesis, cells undergo a sequence of develop-
mental commitment decisions, controlled by extracellular indu-
cing factors, and eventually become one of about 200 different
cell types of the vertebrate body [1]. Differentiated cell types tend
to be relatively stable and to persist long term, with or without
cell division. However it is sometimes possible to reprogramme
one differentiated cell type to another by overexpression of
speciﬁctranscriptionfactorswhichareresponsiblefortherelevant
commitment processes in normal development [2]. The ﬁrst
example of this was the ability of the myogenic factor MyoD
to reprogram a variety of tissue culture cell lines to a myogenic
phenotype [3]. More recently, several other examples have
been described, including the conversion of pancreatic exocrine
cells into hepatocytes [4], B-lymphocytes into macrophages [5],
pancreatic exocrine cells into endocrine cells [6], ﬁbroblasts into
neurons [7] or ﬁbroblasts into cardiomyocytes [8]. Between one
andthreetranscriptionfactorsneedtobeoverexpressedtoachieve
these transformations, typically ones that are involved in the
normalembryonicdevelopmentofthecelltypeinquestion[9,10].
Their function is not simply to activate direct target genes, but to
shift the cell into a new stable state of gene expression. Most
strikingly, it is also possible to use this approach to reprogramme
a variety of normal tissue cells to a state resembling that of
embryonic stem cells (induced pluripotent stem cells, [11,12]).
Indeﬁningacelltype,oneimportantaspectistheconﬁguration
of active genes for the speciﬁc differentiation products. Another
is the conﬁguration of regulatory genes that maintain the state in
a stable manner. For both it is clear that an essential feature of
the differentiated cell state is the chromatin state of key genes.
Two particular types of epigenetic modiﬁcation have been shown
to be important in this context. The modiﬁcation of histone tails,
particularly of histone 3, can cause both positive and negative
effects on gene expression. In general acetylation is thought to be
associated with an active chromatin conﬁguration [13], whereas
histone tail methylation may have either positive or negative
effects, depending on the speciﬁc site in the protein [14]. The
other type of modiﬁcation is DNA base methylation. This occurs
on the 5 position of cytosine in CpG dinucleotides. Active genes
areusuallyassociatedwitharelativeundermethylationofCpGsin
their regulatory regions (CpG islands [15]), and repressed genes
are associated with a high level of methylation in their regulatory
regions. DNA methylation is well established to be heritable
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on cell division, and there is also some evidence that histone
modiﬁcations can be maintained through cell division [16]. Thus
both of these general mechanisms are likely to be basic to the
maintenance of differentiated cell types.
Ofthevariousexamplesofdirectcelltypereprogrammingwith
transcription factors, the ability to make pancreatic beta (β) cells
is of particular interest from the point of view of potential cell
transplantation therapy for diabetes. This is because the clinical
procedure of islet cell transplantation therapy is well established
and the limiting factor is entirely the lack of suitable human
beta cells [17]. The study of Zhou et al. [6], in which pancreatic
exocrine cells were converted into insulin-positive cells, was
conducted in vivo using immunodeﬁcient mice. Because it is
difﬁcult to investigate molecular mechanisms in vivo,w ef e l ti t
important to establish an in vitro model for the process which is
more amenable to study.
We selected the AR42j-B13 cell line for this purpose, referred
to here as B13 cells. This is a rat cell line with a pancreatic
exocrinephenotype,originallyderivedfromachemicallyinduced
pancreatic tumour [18]. It is easy to grow in culture and expresses
amylase and other typical exocrine cell products. It has a
stable phenotype, in contrast with primary cultures of pancreatic
exocrine cells which undergo a rapid ductal transformation in
adherent culture [19], or de-differentiation in suspension culture
[20,21]. Unlike samples of pancreatic tissue from animals, which
contain many cell types such as connective tissue cells and blood
vessels in addition to the epithelium, a culture of B13 cells
contains only one cell type, making biochemical measurements
more meaningful. Although there are reports in the literature
of insulin-positive cells arising from this line following culture
on Matrigel and treatment with various growth factors [22,23],
we have not used such conditions in the present study and see
no spontaneous endocrine differentiation of the cells under the
conditions used.
In the present study we describe the effects of Pdx1 (pancreatic
and duodenal homeobox 1)+Ngn3 (neurogenin 3)+MafA (v-
maf musculoaponeurotic ﬁbrosarcoma oncogene family, protein
A), the gene combination used by Zhou et al. [6], on the B13
cells. Pdx1 is a major pancreatic transcription factor belonging
to the ParaHox family, which is necessary both for formation
of the pancreatic buds in the embryo and subsequently for beta
cell formation and function [24,25]. Ngn3 is a member of basic
helix-loop-helix transcription factor family and it is essential for
the formation of endocrine progenitor cells during pancreatic
development [26]. MafA is a member of the basic leucine zipper
transcription factor family and it is needed for maturation of beta
cells[27].Inadditiontotheirdevelopmentalfunctions,bothPdx1
andMafApositivelyregulateinsulingeneexpressioninbetacells.
We introduced the three transcription factor genes using a
singleadenoviralvector,Ad-PNM(adenoviralPdx1,Ngn3,MafA
construct), ensuring that all transduced cells receive the same
genes. We ﬁnd that a high proportion of transduced cells alter
morphology,down-regulateexpressionofexocrineproducts,such
as amylase, trypsin and carboxypeptidase A, and express insulin
from both of their insulin genes. The chromatin state of insulin
genes is moved toward the beta-cell state in respect both of
histonetailmodiﬁcationsandDNAmethylation.Thecellsacquire
various additional properties of pancreatic beta cells and are
capable of relieving diabetes following transplantation into an
experimental mouse model of diabetes. However, we also ﬁnd
that some important beta cell transcription factors are not up-
regulated and that the vital glucose-sensing mechanism of beta
cells is not present in these cells. We therefore conclude that
the reprogramming achievable with these three genes, although
dramatic, is not complete.
EXPERIMENTAL
Recombinant adenovirus preparation
The Pdx1, Ngn3 and MafA genes from the mouse were used
to construct a single adenovirus encoding all three transcription
factors, called Ad-PNM. Full-length mouse Pdx1 and Ngn3
cDNAs were ampliﬁed by PCR to replace their translational
termination codons with speciﬁc restriction sites and cloned into
pBluescript (KS
+/−) as a XbaI/BamHI fragments. The Pdx1
cDNA and Ngn3 cDNA were then ligated to the coding region
for the 18-amino-acid peptide 2A from FMDV (Foot and Mouth
Disease virus) to generate pBS–Pdx1–2A and pBS–Ngn3–2A.
They were then joined such that the coding region of the 2A was
followed by the ﬁrst amino acid codon of the Ngn3 coding region
to make the construct pBS–Pdx1–2A–Ngn3–2A. This was then
ligated to the MafA cDNA including the translational termination
codon and cloned as BglII/EcoRV fragment in pBluescript
(KS
+/−) in the same way to generate the polycistronic cons-
truct PNM (pBS–Pdx1–2A–Ngn3–2A–MafA). The PNM
construct was taken out as a single SalI fragment using the sites
present internally upstream of Pdx1 and downstream of MafA,
and cloned into the shuttle vector pShuttleT2ALCAG5PL4–
7. Recombinant adenovirus containing the PNM construct was
produced by homologous recombination after electroporating
the linearized shuttle vector into BJ5183 bacterial cells. This
was done using the pAdEasy adenoviral vector system (Agilent
Technologies) according to the manufacturer’s instructions.
Ad-GFP (green ﬂuorescent protein) was used for various
control experiments. Its preparation is described in [28].
Cell culture and virus administration
The rat pancreatic exocrine cell line (AR42J-B13, referred to
here just as B13) was obtained from Dr David Tosh(University of
Bath, Bath, U.K.) and grown in low-glucose DMEM (Dulbecco’s
modiﬁed Eagle’s medium; Gibco) supplied with 10% (v/v)
FBS (fetal bovine serum; Hyclone) and 1× anti-anti (antibiotic-
antimycotic; Gibco) solution. The rat insulinoma cell line (RIN-
m5F) (A.T.C.C. Manassas, VA, U.S.A) was grown in high-
glucose DMEM (Gibco) supplied with 10% (v/v) FBS and
1× anti-anti solution. IRPT (immortalized rat kidney proximal
tubular) cells were obtained from Dr Shunan Li (University of
Minnesota, Minneapolis, MN, U.S.A.) and were grown in low-
glucose DMEM supplied with 5% (v/v) FBS and 1× anti-anti
solution. Media were replaced every 2 days.
B13 cells were transduced with a dose of 25 MOI (multiplicity
of infection) Ad-PNM and the next day the virus including
medium was replaced.
RT–PCR (reverse transcription–PCR)
Total RNA was isolated using the RNeasy Mini Kit (Qiagen),
according to the manufacturer’s instructions. RNA samples were
then treated with DNase (Promega) to remove genomic DNA.
A PCR was run with the RNA template at 60◦C for 35
cycles to conﬁrm the absence of genomic DNA contamination.
cDNAs were then synthesized by reverse transcription from
2 μg of total RNA using SuperScript III Reverse Transcriptase,
oligo(dT)20 anddNTP(10 mM)(Invitrogen).Thegeneexpression
pattern between B13 cells with and without Ad-PNM was then
compared by performing PCR for rat Ins (insulin) 1, Ins2
(insulin 2), Gcg (glucagon), Ppy (pancreatic polypeptide), Sst
(somatostatin), Iapp (islet amyloid polypeptide), Pax (paired
box gene) 4, Neurod1 (neurogenic differentiation 1), Nkx [NK
(natural killer) 2 transcription factor related] 2.2, Arx (aristaless
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related homeobox), Pdx1, Ngn3, MafA, Nkx6.1, Isl1 (ISL1
transcription factor, LIM/homeodomain), Mnx1 (motor neuron
and pancreas homeobox 1 also known as Hlxb9), Pax6, Hes1
(hairy and enhancer of split 1), Slc2a2 [solute carrier family
2 (facilitated glucose transporter), member 2 also known as
Glut2],Kcnj11(potassiuminwardlyrectifyingchannel,subfamily
J, member 11 also known as Kir6.2), Abcc8 (ATP-binding
cassetteC8alsoknownasSur1),Amy(amylase),Ptf1a(pancreas-
speciﬁc transcription factor 1a), Cpe (carboxypeptidase E), Pcsk2
(proprotein convertase subtilisin/kexin type 2), Prss1 (trypsin 1),
Cpa (carboxypeptidase A1; 27 cycles), Ctrb1 (chymotrypsingoen
B1; 25 cycles), Rbpj1 (recombination signal binding protein for
Igκ J region; 26 cycles) and Actb (β-actin), in addition to mouse
Pdx1, Ngn3 and MafA. Rat pancreas cDNA was used as a positive
controlforGcg,Sst andPpy.cDNAfromAd-PNM-infectedHEK
(human embryonic kidney)-293 cells was used as positive control
for the input genes mouse Pdx1, mouse Ngn3 and mouse MafA.
cDNA from RIN-m5F cells was used as positive control for the
restofthegenes.ThePCRconditionswere:94◦Cfor3 mininitial
denaturation,94◦Cfor30sdenaturation,60◦Cfor30sannealing,
72◦C for 1 min extension and 72◦C for 5 min ﬁnal extension,
and overall 30 cycles were performed unless otherwise indicated.
Primers used for RT–PCR are listed in Supplementary Table S1
(at http://www.BiochemJ.org/bj/442/bj4420539add.htm). PCR
products were run on a 1% (w/v) agarose gel (Invitrogen) in TAE
(Tris/acetate/EDTA)buffer(Bio-RadLaboratories)withethidium
bromide by electrophoresis at 100V. Gels were visualized with a
Bio-Rad Laboratories gel documentation system model 2000.
qRT–PCR (quantitative RT–PCR)
Ad-PNM-treated B13 cells were kept in DMEM supplemented
with 200 μM of the anti-mitotic agent araC (cytosine
arabinofuranoside;Sigma)tosuppressthecontinuedproliferation
of untransformed B13 cells. RNA isolation and cDNA synthesis
from these cells were performed as described above. The gene
expression pattern between B13 cells with and without Ad-PNM
was then compared by performing qRT–PCR for rat Ins1, Ins2,
Iapp, Pax4, Neurod1, Nkx2.2, Arx, endogenous Pdx, endogenous
Ngn3, endogenous MafA, Isl1, Mnx1, Hes1, Slc2a2, Kcnj11,
Abcc8, Amy, Ptf1a, Cpe, Pcsk2, Pcsk1, Prss, Cpa, Ctrb1,
Rbpj1 and Gapdh (glyceraldehyde-3-phosphate dehydrogenase).
qRT–PCR conditions were 95◦C for 30 sec initial denaturation,
95◦C for 5 sec denaturation, and 60◦C for 10 sec annealing and
extension, and overall 40 cycles were performed. The primers
used for the qRT–PCR are listed in Supplementary Table S1.
Immunostaining
B13 cells were ﬁxed with 4% (w/v) paraformaldehyde (Sigma)
in PBS (Sigma) for 20 min. After ﬁxation cells were washed
three times with PBS-T [0.1% Tween 20 (Bio-Rad Laboratories)
in PBS] for 5 min in each wash. Cells were then permeabilized
with 0.2% Triton X-100 (Sigma) in PBS for 15 min. After 1 h of
blocking with PBS-T containing 1% (w/v) BSA (Sigma), cells
wereincubatedovernightwithprimaryantibodiesat4◦Candthen
for 1 h with secondary antibodies at room temperature (20◦C).
The primary antibodies used were: guinea pig anti-insulin (1:200
dilution; Sigma); rabbit anti-Pdx1 (1:2000 dilution; Upstate
Biotechnology); rabbit anti-C-peptide (1:100 dilution; Cell
Signaling Technology), rabbit anti-Ngn3 (1:100 dilution; Santa
Cruz Biotechnology); and rabbit anti-MafA (1:100 dilution;
Santa Cruz Biotechnology). The secondary antibodies used are as
follows: Alexa Fluor® 480 goat anti-rabbit IgG (1:500 dilution;
Invitrogen) and Alexa Fluor® 594 goat anti-guinea pig IgG
(1:500 dilution; Invitrogen). Images were taken using a Leica
DMI6000 B inverted microscope.
EdU (5-ethynl-2-deoxyuridine) labelling and staining
B13cells(5×10
5)wereplatedineachwellofsix-wellplates.EdU
(10 μM)fromtheClick-iTEdU594ImagingKit(Invitrogen)was
usedforlabelling.Aftertheincubationcellswereﬁxedandstained
forEdU,accordingtothemanufacturer’sinstructionstodetectthe
number of cells in cycle during the EdU treatment. Images were
taken using a Leica DMI6000 B inverted microscope.
ELISA for total insulin content and glucose-stimulated
insulin release
B23 cells (5×10
5) were plated in each well of a six-well plate.
Cells in three wells were kept without Ad-PNM as controls. The
cells in the remaining three wells were transduced with Ad-PNM
overnight, after which the medium was changed. At 3 days after
Ad-PNM administration, DMEM was removed and cells were
incubated either with 2.8 mM or 20 mM glucose in KRB (Krebs–
Ringer buffer) for 1 h at 37◦C. In some experiments 30 mM KCl
was included to effect depolarization of the cells. The KRB was
then removed and kept at −20◦C for measurement of insulin
release into the medium. After the removal of KRB, the cells
were scraped into 0.18 M HCl/35% ethanol. The cells were
homogenized by sonication with a Branson Soniﬁer 450 (6×
10 s on ice with 1 min waiting on ice between pulses) and rotated
overnight at 4 ◦C. The next day, the cells in acid/ethanol were
subjected to centrifugation (10000 g for 30 min at 4◦C). The
supernatant was kept at −20◦C to measure the total amount of
insulin in the cells. The remaining cell pellets were resuspended
in0.1 MNaOHtomeasurethetotalamountofproteininthecells.
The amount of the insulin released into the medium and the total
insulin in the cells were measured using an Ultrasensitive Rat
Insulin ELISA kit (Mercodia), according to the manufacturer’s
instructions. The total protein amount in the cells was measured
using the BCA (bicinchoninic acid) protein assay kit (Thermo
Scientiﬁc), according to manufacturer’s instructions.
ChIP (chromatin immunoprecipitation) for histone tail
modiﬁcations and qPCR (quantitative PCR)
B13 cells (10
7) with no Ad-PNM, B13 cells 3 days after
administration of Ad-PNM, RIN-m5F cells or IRPT cells were
plated on 20 cm tissue culture dishes. Formaldehyde (36.5%;
Sigma) was added to the dishes to ﬁnal concentration of 1%
in each dish. After 10 min incubation, the cross-linking reaction
was quenched by addition of 2 ml of 1.25 M glycine (Sigma).
The cells were subjected to centrifugation (10000 g for 15 min
at 4◦C) and the supernatant was discarded. Cell and nucleus
lysis buffers (Magna ChIP
TM G Kit, Millipore) were added to
the cell pellets. The cells/DNA were sheared by sonication using
a Branson Soniﬁer 450 (15×10 s on ice with 1 min waiting on
ice between pulses). Then ChIP was performed for H3K4Me3
(trimethylated Lys
4 of histone 3), H3K9Me2 (dimethylated Lys
9
of histone 3), H3K27Me3 (trimethylated Lys
27 of histone 3)
and H3Ac (acetylated histone H3) by using Magna ChIP
TM G
Kit (Millipore), according to the manufacturer’s instructions.
Antibodies used for ChIP were: a rabbit anti-H3K4Me3 mAb
(monoclonal antibody; Cell Signaling Technology), mouse anti-
H3K9Me2 mAb (Abcam) and mouse anti-H3K27Me3 mAb
(Abcam) and rabbit anti-H3Ac polyclonal antibody (Millipore).
For each immunoprecipitation reaction 5 μg of antibody was
used. After immunoprecipitation of DNA fragments bearing the
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histone modiﬁcations mentioned above, qPCR was performed
by using speciﬁc primer pairs (Supplementary Table S1)
spanning approximately −200 bp to +50 bp of the Ins1,
Ins2 and Pdx1 genes. This region includes a number of
important regulatory sites as shown in Supplementary Figure S1
(at http://www.BiochemJ.org/bj/442/bj4420539add.htm) [29–
33]. qPCR conditions were: 50◦Cf o r2m i n ,9 5 ◦C for 10 min
initial denaturation, 95◦C for 15 s denaturation, 60◦C for 30 s
annealing and 60◦C for 30 s extension (overall 40 cycles were
run) using a Eppendorf Realplex
4 mastercycler. To normalize the
ChIP data, the fold enrichment method was used in which ChIP
signals were divided by non-speciﬁc antibody signals.
DNA methylation assay with bisulﬁte sequencing
Genomic DNA isolation from B13 cells with no Ad-PNM
and from B13 cells with 3 days after Ad-PNM, RIN-m5F
cells or IRPT cells was performed with QIAamp DNA Mini
Kit (Qiagen), according to the manufacturer’s instructions.
Bisulﬁte conversion of isolated genomic DNA was performed
with the EZ DNA methylation-gold kit (Zymo Research),
according to the manufacturer’s instructions. Bisulﬁte-treated
DNA-speciﬁc primer pairs (Supplementary Table S1) which
span the proximal promoters and ﬁrst exons of Ins1, Ins2 and
Pdx1 genes (Supplementary Figure S1) were designed by using
MethPrimer software [34]. To amplify the bisulﬁte-treated
genomic DNA, PCR was performed as follows: 95◦Cf o r
10 min initial denaturation, 95◦C for 30 s denaturation, 50◦Cf o r
40 s annealing, 72◦C for 1 min extension and 72◦Cf o r7m i n
ﬁnal extension, and overall 40 cycles were performed. Hot Taq
DNAPolymerase(ZymoResearch)wasusedinthesePCRs.PCR
products were run on 1% (w/v) agarose gel in 1× TAE buffer
by electrophoresis at 100 V. DNA fragments of interest were
puriﬁed from the gel with Wizard SV Gel and PCR Clean-Up
System (Promega), according to the manufacturer’s instructions.
Puriﬁed PCR products were cloned into the pCR4-TOPO
vector with TOPO TA Cloning Kit (Invitrogen) for subsequent
sequencing. Plasmids including the DNA fragments of interest
were transformed into the chemically competent One Shot
TOP10 cells provided by the kit, according to the manufacturer’s
instructions. Cells were grown on LB (Luria–Bertani) agar plates
containing kanamycin. From each plate ten colonies were picked
up randomly and grown in kanamaycin LB broth overnight at
37◦C. The next day plasmid DNA isolation was performed with
Wizard Plus SV Minipreps DNA Puriﬁcation System (Promega),
according to the manufacturer’s instructions. Each collected
clone was restriction-digested with EcoRI (Promega) to verify
that they contain the DNA fragments of interest. Then ten
different clones for each DNA fragment were sequenced by the
DNA Sequencing and Analysis Facility, Biomedical Genomics
Center, University of Minnesota, MN, U.S.A.
Mouse experiments
For the cell transplantation experiments, adult male NOD-
SCID (non-obese diabetic severe combined immunodeﬁciency)
mice weighting 22–27 g (up to 42 days old) were injected
intraperitoneally with STZ (streptozotocin; Sigma) at a dose
of 120 mg/kg of body mass. Mice were considered diabetic if
their blood glucose level reached a stable value over 400 mg/dl.
The diabetic mice were transplanted with Ad-PNM-treated B13
cells or with Ad-GFP-transduced cells as a control. Under the
kidney membrane of each mouse, 2×10
6 cells were transplanted.
Blood was drawn from the tail vein and blood glucose levels
were measured with a glucose meter every 2 days. At 10 days
after cell transplantation, the kidneys with transplanted cells
were removed and blood glucose levels of mice were monitored
for two more days. The blood sugar changes were quantiﬁed
by measuring the area under the curve, and comparisons were
made using a Student’s t test. The excised kidneys were ﬁxed in
10% (v/v) formalin (Fisher) and processed for tissue sectioning.
After antigen retrieval, sections were stained for insulin, E-
cadherin and DAPI (4
 ,6-diamidino-2-phenylindole) as described
above.Themouseanti-E-cadherin(1:500dilution;BDBioscience
Pharmingen) primary antibody and Alexa Fluor® 488 goat anti-
mouse IgG (1:500 dilution; Invitrogen) secondary antibody were
used to stain E-cadherin protein.
For expression of Pdx1, Ngn3 and MafA in the exocrine
pancreas, adult CD1 mice were anaesthetized with avertin. A
portion of skin was shaved and wiped with betadine. A small
incision was then made and the pancreas everted from the wound.
Ad-GFP or Ad-PNM (100 μl; 10
11 plaque-forming units/ml)
were injected into the splenic lobe of the pancreas using an
insulin needle. This caused formation of a visible bubble of
ﬂuidwithinthepancreas.Thepancreaswasreinternalizedandthe
wound repaired in layers. The mice were killed 7 days later. The
pancreases were removed, ﬁxed in 10% (v/v) formalin (Fisher)
and processed for tissue sectioning (frozen for GFP and parafﬁn
for immunostaining). Sections were stained for insulin and Ngn3
as described above.
The animal experiments were carried out under IACUC
(Institutional Animal Care and Use Committee) protocol
1007A85640 of the University of Minnesota.
RESULTS
Effects of Pdx1, Ngn3 and MafA on B13 cells
When three adenoviruses carrying different genes are used to
transduce cells, they do so at random such that individual cells
may receive one, two or three genes. To remove this source
of variation we made an adenoviral vector carrying all three
genes in order that all transduced cells would receive all
three (Figure 1A). The three coding regions are joined by
2A sequences, which cause autocleavage of the extending
polypeptide during protein synthesis [35]. The whole is driven
by the highly active cags (cytomegalovirus-chicken β-actin)
promoter [36]. We conﬁrmed that this vector would infect cells
efﬁciently and that all three proteins could be detected by
immunostaining (shown in Figure 2). Trials of different viral
doses indicated that for B13 cells the optimum MOI was 25 and
this dose was used in the experiments to be described. The day
after virus administration, cells changed their shape from an oval
structure to a more ﬂattened ﬁbroblast-like shape (Figure 1B). A
control virus encoding GFP did not have this effect, showing that
it is not a consequence of virus infection itself.
Ad-PNM also altered the gene expression pattern. RT–PCR
results are shown at 3 days and qRT–PCR over a time course
of 12 days (Figures 1C and 1D). For the 12 day studies cells
were cultured in the presence of araC. This kills dividing
cells and thus removes the minority of untransduced cells that
continue to divide and would otherwise overgrow the cultures.
These results therefore reﬂect just the transduced cells. They
started to express Ins1 and Ins2 genes (rodents have two insulin
genes encoding similar products). Expression of Iapp and Pax4,
which are not normally expressed in B13 cells, were also up-
regulated. Moreover, these cells elevated the expression level
of genes encoding the beta cell transcription factors Neurod1,
Nkx2.2 and the pro-insulin processing enzymes cpe and Pcsk2
which are all expressed to some extent in the untreated cells.
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Figure 1 Effect of PNM on cell shape and gene expression proﬁle of B13 cells
(A) Diagram ofthe Ad-PNM construct.CAGS,cytomegalovirus-chicken β-actin. (B) Shapeof theB13 cells with no treatment, Ad-PNM or Ad-GFP.Imagesweretaken 3daysafter virustransduction.
Scalebars=100μm.(C)ChangesinthegeneexpressionproﬁleofB13cells,withandwithoutAd-PNM,byRT–PCR.Fromlefttorightthelanesareasfollows:untreatedB13cells,B13cells3 days
after Ad-PNM,positivecontrolsampleandwater (negativecontrol).Inputgeneexpressionislabelled asmPdx1,mNgn3andmMafA. Eachhorizontalstrip comesfromasinglegelbutdifferentstrips
may come from different gels. The results for Abcc8/Sur1, Prss1, Cpa1, Ctrb1 and Rbpjl were obtained with the qRT–PCR primers. (D) Changes in the gene expression proﬁle of B13 cells, with and
without Ad-PNM, by qRT–PCR. From left to right the bars are as follows: untreated B13 cells as day 0, Ad-PNM-treated B13 cells as day 3, day 6, day 9 and day 12. Cultures were kept in araC to
remove untransduced B13 cells. The heights of bars shows the expression relative to the housekeeping gene Gapdh. Results are means+ −S.E.M. (n=3).
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Figure 2 Expression of insulin and exogenous Pdx1, Ngn3, MafA
B13 cells were ﬁxed and stained 3, 6, 9, 12days after Ad-PNM transduction. Cells were then co-stained for insulin (red) and Pdx1 (green) (A), insulin (red) and Ngn3 (green) (B), insulin (red) and
MafA (green) (C). (D) Percentage of insulin-positive cells out of the population of PNM-positive cells. Data are means+ −S.E.M. (n=3). (E) C-peptide (green), insulin (red) and DAPI (blue) at day
12. (F) Amylase (green), insulin (red) and DAPI (blue) at day 6. Scale bars=100μm.
One of the genes for the ATP-sensitive potassium channel Sur1
(Abcc8) was up-regulated, but the gene for another component of
this channel, Kir6.2 (Kcnj11), was not. In contrast with the beta
cell markers, the expression of all the exocrine markers (Amy,
Prss1, Cpa1, Ctrb1, Rbpj1 and Ptf1a) was down-regulated, as
was the centroacinar marker Hes1. The fall in Amy, Prss1 and
Cpa1 transcripts was approximately 100-fold, whereas that of
Ctrb1, Rbpj1 and Ptf1a was approximately 10-fold. There was
no up-regulation of the genes encoding the hormones produced
by the non-beta endocrine cell types found in the pancreas: Gcg,
Ppy, Sst and Ghrl (ghrelin).
Thus in a number of respects the Ad-PNM-treated B13 cells
appeared to have a phenotype more resembling that of pancreatic
beta cells than of pancreatic exocrine cells. On the other hand,
apart from Abcc8 (Sur1), other genes for beta cell membrane
channel proteins, such as those encoding Slc2a2/ (Glut2) and
Kcnj11 (Kir6.2), were not signiﬁcantly up-regulated (Figures 1C
and 1D). The ability to secrete insulin in response to a rise
in external glucose concentration is a key attribute of the beta
cell, and the essential components of this mechanism are not
all induced, indicating that the reprogramming of cell type is
incomplete. Also, the reduction of exocrine gene expression,
although striking, is not a complete extinction. Furthermore,
expression is not induced from the endogenous counterparts of
the three input genes. The viral-encoded Pdx1, Ngn3 and MafA
are mouse sequences and so their mRNA can be distinguished
from those of the rat B13 cells using suitable primers. Although
the expression of Ngn3 might be expected to be conﬁned to the
period of formation of endocrine precursors, we would expect to
see Pdx1 and MafA expressed long-term in genuine beta cells,
and it is not seen.
We also performed immunostaining for insulin, its side product
C-peptide, the major exocrine protein amylase, and the three
input proteins Pdx1, Ngn3 and MafA. The majority of Ad-
PNM-transduced cells started to express insulin protein by 3 days
(Figure 2) and these insulin-positive cells can persist for at least
4 weeks. Not all of the virus-transduced cells became insulin-
positive,butabout70%didsoandthisproportionremainssimilar
over at least 12 days (Figure 2D). C-peptide was found to be
present and to be co-localized with insulin. C-peptide is normally
excised during the maturation of pro-insulin to the mature two-
chain structure and its presence in insulin-positive cells indicates
that the pro-insulin protein is properly processed after expression
(Figure2E).Moreover,asviewedbyimmunostaining,theinsulin-
positive cells completely lost amylase protein which is one of the
major products of pancreatic exocrine cells (Figure 2F). Note that
araC was not used in these experiments so there are still untrans-
duced B13 cells present which are growing rapidly. This provides
the internal positive control for amylase staining in Figure 2(F).
Next we looked at the proliferation ability of B13 cells before
andafterAd-PNMtransduction(Figure3).A4 hpulseofEdUwas
found to label about half of the untreated B13 cells as expected
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Figure 3 Cell proliferation assay with EdU
(A) B13 cells were given EdU for 4h. Then they were ﬁxed and stained for EdU (red) and DAPI (blue). (B) B13 cells were given EduU for 4h. Then the cells were transduced with Ad-PNM. At 3 days
later, cells were ﬁxed and stained for EdU (red), insulin (green) and DAPI (blue). (C). B13 cells were transduced with Ad-PNM. At 3 days later these cells were given EdU overnight. Next day they
were ﬁxed and stained for EdU (red), insulin (green) and DAPI (blue). Scale bars=100μm. The red colour is slightly enhanced in (B and C) to be consistent with (A). (D) Left-hand bar: percentage
of proliferating cells out of total population. Middle and right-hand bars: percentage of proliferating insulin-positive cells out of total insulin-positive cells. Data are means+ −S.E.M. (n=3).
for a rapidly dividing population (Figures 3A and 3D). If Ad-
PNM is added after such a 4 h pulse and insulin-positive cells are
examined 3 days later, a high proportion are labelled, although
somewhat less than 50%, indicating that the transformation may
occur either in cells in S-phase or not in S-phase (Figures 3B
and 3D). However, if the cells were transduced with Ad-PNM,
left for 3 days and then given an overnight label with EdU, the
proportion of insulin-positive cells that are also EdU-labelled is
extremelysmall(Figures3Cand3D).Thisshowsthatcelldivision
ceasesalmostentirelyfollowingthetransformation.Ifovergrowth
by the untransformed B13 cells is suppressed with araC, then
the ﬁbroblast-shaped insulin-positive cells can persist for a long
time. Cultures have been maintained for 4 weeks, although
there is some cell death of the insulin-positive cells over this
period.
Insulin content and secretion in transformed cells
Todetecttheamountoftheinsulinproteinproducedwemeasured
the total insulin amount by ELISA in the B13 cells with or
without Ad-PNM. This showed a substantial increase, although
it did not reach the level of mature beta cells which can contain
as much as 5% of insulin protein as a proportion of total cell
protein (Figure 4A). Because glucose-stimulated insulin release
is the key physiological property of beta cells we examined this
by treating the cells with 2.8 or 20 mM glucose in KRB for
1 h and then analysing the insulin content of the medium by
ELISA(Figure4B).WealsotestedKClwhichproducescomplete
depolarization of beta cells and causes them to emit a maximal
amount of insulin. As expected, there was no insulin secretion
from untreated B13 cells. The Ad-PNM-transduced cells did
secrete insulin, but in a completely unregulated manner, showing
no effect of glucose or of KCl. We conclude that the transformed
cells do secrete insulin in a constitutive, but not a regulated,
manner.
Figure 4 Total insulin and secreted insulin amount by ELISA
(A)ThetotalinsulinamountintheB13cellswithandwithoutAd-PNMwasmeasuredbyELISA.
(B) The amount of insulin in the medium released from B13 cells with and without Ad–PNM
transductionwasmeasuredbyELISA.Cellswerestimulatedeitherwithlow-glucose(openbars)
orhigh-glucose(closedbars)andKCl.ExperimentswithAd-PNM-treatedcellswereperformed
3 days after transduction. Data are means+ −S.E.M. (n=3).
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Figure 5 Changes of the histone tail modiﬁcations at the promoter regions of the Pdx1, Ins1 and Ins2 genes
ChIP assays were carried out to compare the proportion of the histone tail modiﬁcations (H3K4Me3, H3K9Me2, H3K27Me3 and H3Ac) at the promoters of the Gapdh (A), Pdx1 (B), Ins1 (C)a n d
Ins2 (D) genes. The cell types analysed are RIN-m5F cells (stippled bars), B13 cells without Ad-PNM (open bars), B13 cells with Ad-PNM (closed bars) and IRPT cells (diagonal hatched bars). The
y-axis shows fold change of samples over negative control rat IgG. Data are means+ −S.E.M. (n=3).
Effects on histone tail modiﬁcations at Pdx1 and insulin genes
Histonetailmodiﬁcationssuchasmethylationandacetylationcan
be functionally important either for up-regulation or repression of
a gene [13,14]. H3K4Me3 and H3Ac are two of the indicators of
the active transcription when found in histones at the promoter
region of a gene, whereas H3K9Me2 and H3K27Me3 are two of
the indicators of the repression of transcription.
Reprogramming can be expected to activate regulatory genes
controlling the cell phenotype as well as the genes encoding the
differentiation products for the gene in question. For this reason
we examined these four histone tail modiﬁcations at the promoter
of the endogenous Pdx1 gene as well as at the promoters of
the Ins1 and Ins2 genes [29–33] (Figure 5). The Gapdh gene,
which is active in all cell types, was used as positive control
(Figure 5A). We compared RIN-m5F cells (a rat insulinoma line
which is Ins1
+, Ins2
+ and Pdx1
+), B13 cells without Ad-PNM
(whichareIns1
−,Ins2
− andPdx1
−),theB13cellswithAd-PNM
(which are Ins1
+, Ins2
+ and Pdx1
−) and IRPT cells (a rat kidney
line which is Ins1
−, Ins2
− and Pdx1
−). ChIP was performed
for H3K4Me3, H3K9Me2, H3K27Me3 and H3Ac modiﬁcations
followed by qRT–PCR for the promoter region under study. For
Ad-PNM-transduced cells, ChIP was conducted 3 days after viral
transduction.
At the Pdx1 promoter of the B13 cells, Ad-PNM increased
the proportion of H3K4Me3 to a modest extent and it did
not change the level of H3K9Me2, H3K27Me3 or H3Ac
(Figure 5B). This is consistent with the failure to activate
the endogenous gene as shown by the RT–PCR studies. At
both the Ins1 and Ins2 promoters of B13 cells, Ad-PNM reduced
the inhibitory H3K9Me2 and H3K27Me3 proportions to a degree
(not statistically signiﬁcant for Ins2 H3K27Me3) (Figures 5C
and 5D). This is consistent with the up-regulation of both of
these genes as shown by RT–PCR. We had hypothesized that the
chromatin for regulatory genes such as Pdx1 might be ‘open’ in
pancreaticexocrinecellsand‘closed’innon-pancreaticcellssuch
as the kidney. As shown in Figure 5(B) this is the case in relation
to the H3K4Me3 and the two inhibitory indicators. However since
we see no signiﬁcant up-regulation of endogenous Pdx1 with Ad-
PNM it may be that the chromatin is not really accessible and
is rendered inactive by other modiﬁcations not examined in the
present study.
Effects on promoter methylation at Pdx1 and insulin genes
In addition to histone tail modiﬁcations, DNA base methylation
at promoter regions of the genes is another important epigenetic
factor affecting gene expression. The methylation of cytosines
at CpG islands is usually associated with repression of gene
activity [15]. To see whether Ad-PNM changes the DNA
methylation pattern in treated cells, we compared the same four
cellpopulationsusedfortheChIPanalysisandperformedbisulﬁte
sequencing for the same promoter regions of Pdx1, Ins1 and
Ins2 genes. The results indicate that the expression of the Pdx1
gene is not under the control of DNA methylation at the sites
examined, as there is no CpG methylation at either proximal
promoter or exons in any of the cell types. However, expression
oftheIns1gene correlated with DNA methylation atthe proximal
promoter (Figure 6A). In RIN-m5F cells (which are Ins1
+), the
CpG methylation ratio was only 2% at the proximal promoter as
compared with 63% for the whole gene. In IRPT cells (which
are Ins
−), the CpG methylation ratio was 90% at the proximal
promoter compared with 47% for the whole gene. This suggests
that demethylation of the proximal promoter of the Ins1 gene is
necessary for gene expression. As with IRPT cells, the proximal
promoter of B13 cells (which are Ins
−) is highly methylated at
90%. After addition of Ad-PNM (such that the cells become
Ins1
+), proximal promoter CpG methylation was reduced to
28%, with little change of methylation in the Ins1 exon. Unlike
Ins1, the expression of the Ins2 gene may not be under the
control of DNA methylation at the sites examined as there was no
correlation with expression state. In the RIN-m5F cells (Ins2
+),
themethylationratiowas88%attheproximalpromoterand89%
throughoutthewholegene.InIRPTcells(Ins2
−),themethylation
ratio was42%attheproximalpromoterand40%throughoutthe
wholegene.AfterAd-PNMtreatmentthemethylationratioinB13
cellsfellslightlyfrom40%to35%attheproximalpromoterand
from 54% to 49% throughout the whole gene (Figure 6B).
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Figure 6 Changes of the DNA methylation pattern of the Pdx1, Ins1 and Ins2 genes after transduction with Ad-PNM
Comparison of the CpG methylation pattern of the Ins1 (A), Ins2 (B)a n dPdx1 (C) genes in RIN-m5F cells, B13 cells with and without Ad-PNM, and IRPT cells. Each circle, divided into ten wedges,
representstendifferentclonesforthesameCpG.OpenwedgesrepresentunmethylatedCpGsandclosedwedgesrepresentmethylatedCpGs.IntactopencirclesrepresentCpGsthatwerenotcovered
by the bisulﬁte sequencing. UTR, untranslated region.
In summary, the DNA base methylation study indicates that
there is no pre-existing competence of these genes for up-
regulation in the pancreatic cells as compared with the kidney
cells, and that of the genes examined Ins1 shows promoter de-
methylationfollowingAd-PNMtreatment,whereasIns2doesnot.
Insulin-expressing B13 cells rescue diabetic mice
In diabetes research a standard assay for a beta cell phenotype
consists of a transplantation assay to ameliorate diabetes in
experimentalanimals.Forthispurposeweusedimmune-deﬁcient
(NOD-SCID) mice which will tolerate a graft of rat cells. Despite
their name (non-obese diabetic), these mice are not diabetic,
and diabetes is induced by an injection of the toxin STZ, which
destroys beta cells to generate a model of Type 1 diabetes.
Oncediabetes(bloodglucose>400 mg/dl)wasestablished,we
transplanted cells under the kidney capsule and then monitored
the mice every 2 days. The fall in blood glucose indicates a relief
of the diabetes. Following this, the grafted kidneys were removed
for analysis. The rise of blood glucose at this point indicates that
the relief of diabetes was in fact due to the graft and not to a
non-speciﬁc effect of surgery or to consequent effects on feeding
behaviour.Theseexperimentswereterminatedat20 daysbecause
there is a risk of tumour formation from residual non-transformed
B13 cells.
Figure 7(A) shows three mice that were successfully engrafted
with Ad-PNM-treated cells. Immunostaining of kidney sections
from the excised kidneys demonstrated the persistent presence of
insulin-positive rat cells under the kidney capsule (Figure 7B).
The controls consisted of one mouse receiving Ad-GFP-treated
cells and three receiving Ad-PNM-treated cells, but where the
graft did not take. The results were quantiﬁed by measuring the
area under the curve for each mouse from days 9–17 inclusive.
This gave mean values of 1285 (S.D.=426) for the active grafts,
2531 (S.D.=385) for the grafts that did not take, and 2780 (S.D.)
for the diabetic control. Comparison of the active grafts with
those that did not take showed a P value of 0.020. Comparison
of the active grafts with diabetic control gave a P value of 0.026.
By contrast, comparison of the grafts that did not take with the
diabetic control showed no difference (P=0.379). This result
indicates that the Ad-PNM-treated cells are capable of relieving
diabetes in an animal model, even though they do not exhibit
glucose-sensitive insulin secretion.
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Figure 7 Amelioration of diabetes by Ad-PNM-transduced B13 cells
(A) Mice were given STZ to induce diabetes at day 0. Cells were transplanted under the kidney
capsule at day 7 (grey arrow). Blood glucose levels were then measured every 2 days. At day
17 the transplanted kidneys were removed and analysed for the presence of graft cells (black
arrow). ,Ad-GFP-treatedcells(control);,Ad-PNM-treatedcells,n=3andonemousedied
after kidney removal; , Ad-PNM-treated but without successful engraftment, n=3. Results
are means+ −S.E.M. (B) Explanted kidneys were stained for insulin (red), E-cadherin (green)
and DAPI (blue). Scale bar=100μm.
Transduction of exocrine pancreas in vivo
Ad-GFP or Ad-PNM were injected directly into the pancreas as
describedpreviously[6]andtheresultsareshowninFigure8.Ad-
GFPgivesaveryhighefﬁciencyoftransductioninexocrinetissue,
with most cells expressing GFP protein. A small number of beta
cells in the islets, visualized by immunostaining for insulin, were
also transduced (Figure 8A). When a similar dose of Ad-PNM
wasgiven,ahighleveloftransductionwasdetectedbyexpression
of the vector-encoded proteins. Figure 8(B) shows the expression
of Ngn3, which is not normally found in mature exocrine
or endocrine cells. The sections were stained for insulin
and it was evident that a proportion of the scattered cells
expressing Ngn3 were also expressing insulin. The insulin
expression was not necessarily observed in those cells
expressing the highest levels of Ngn3, rather it was more
likely to be observed in those with intermediate levels.
This experiment conﬁrms that the basic observation of Zhou
et al. [6] is correct. On the other hand it is difﬁcult to establish
for certain the phenotype of scattered cells in vivo. Consistent
with the study of the B13 cells, the insulin-positive cells in vivo
superﬁcially resemble exocrine cells making insulin, rather than
true beta cells.
DISCUSSION
The direct reprogramming of differentiated cells is of interest for
two reasons. It is an important intellectual issue because it raises
thequestionofwhetherthe200orsovisiblecelltypesaretheonly
possiblestablestatesofvertebratecellsorwhethernumerousother
states are potentially stable but are not accessed during normal
development. This can be experimentally probed by studies in
which developmental transcription factors are misexpressed in
order to drive cells into a new developmental state. Because of
the dense web of regulatory connections between developmental
transcription factors, overexpression of a small number of factors
can sometimes push the cell into a new state which involves a
change in activity of thousands of genes.
In the case of transformation to a beta cell phenotype, direct
reprogramming is also important from a practical point of view.
The technique of islet cell transplantation has been practiced on
a modest scale for the last 10 years and is used especially for
cases of Type 1 diabetes showing unawareness of hypoglycaemia
[17]. This is potentially life threatening as it can lead to
sudden loss of consciousness. In the technique, islets from the
pancreas of human cadaver donors are infused into the portal
vein and lodge in the liver, where they can survive and function
effectively. This is a successful type of cell transplantation
therapyastheunawarenessofhypoglycaemiaresolvesinvirtually
all patients and a proportion become insulin-independent for
some years. However, the supply of cells is highly limited and
there are many problems associated with the obligatory lifelong
immunosuppression. In this context, the possibility of creating
new beta cells from a tissue of an individual patient would be of
great importance since it would resolve both the problem of cell
supply and of alloimmunity.
Figure 8 Transduction of the exocrine pancreas in vivo
(A) Injection of pancreas with Ad-GFP, visualized by GFP ﬂuorescence, showing a high level of transduction in exocrine tissue. (B) Transduction with Ad-PNM, immunostained for Ngn3 (green) and
insulin (red). Scale bars=100μm.
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We were motivated to conduct the present study following the
publication by Zhou et al. [6]. This showed the induction of
insulin-positive cells in the exocrine pancreas of mice following
direct injection of an adenovirus encoding the three genes Pdx1,
Ngn3andMafA.AsweshowinFigure8,thereisnodoubtthatthe
procedure can induce ectopic insulin-positive cells, but it is less
easy to prove that they are indeed beta cells with the full range of
properties expected of this cell type.
In order to facilitate mechanistic studies we employed a well-
known in vitro model of pancreatic exocrine cells, the cell
line AR42j-B13. Our results show that there is a remarkable
phenotypic change in these cells following the introduction of
the three genes. They change morphology to a ﬂat ﬁbroblast-like
shape, stop dividing, down-regulate the expression of a range
of exocrine markers, express insulin from both the endogenous
genes and display a number of characteristic transcription factors
normally found in beta cells. However, the transformation is not
complete,astheendogenouscounterpartsoftheintroducedgenes
are not up-regulated, and some components of the all-important
glucose-sensing mechanism of beta cells are not induced. We
showed this both from the lack of expression of the Slc2a2 (also
known as Glut2) and Kcnj11 (also known as Kir-6.2) genes and
from the lack of glucose-induced insulin secretion by these cells.
Signiﬁcantly, a previous study by Aldabbiat et al. [23], involving
formation of insulin-positive cells from AR42j cells cultured
on Matrigel and treated with growth factors, also reported no
regulated insulin secretion.
During pancreatic development both exocrine and endocrine
cells arise from the same endodermal cell population of
the pancreatic bud [37,38]. It is possible that the endocrine
and exocrine cells might share some aspects of chromatin
state as a result of their developmental relatedness, and this
may facilitate interconversion by overexpression of selected
transcription factors. For example, in exocrine cells perhaps
the genes characteristic of endocrine cells, while not expressed,
are still accessible to transcription factors rather than being
sequestered in inactive regions of chromatin. For this reason we
made the study of the histone tail modiﬁcations and DNA base
methylation of Pdx1 and the two insulin genes. In the case of
Pdx1, which is a key regulatory gene in pancreatic development,
the histone methylation studies did suggest an open conﬁguration
in the pancreatic, but not the non-pancreatic, cell types. Although
our line of B13 cells does not express Pdx1, other lines of the
original cells in use elsewhere have been reported to do so in
their normal state [23,39]. With regard to the insulin genes, the
results of the histone methylation and DNA methylation studies
indicatethattheintroductionofthePNMfactorcombinationitself
modiﬁes the chromatin to promote expression.
If cellular reprogramming to beta cells does eventually become
a method for clinical use, it is likely to take the form of
in vitro cell transformation followed by a graft similar to the
current islet transplantation procedure. This is because direct
introduction of genes into the pancreas is likely to pose risks of
oncogenic transformations as seen in other types of gene therapy
[40]. Thus it is necessary to show that the transformed cells can
indeed cure diabetes following transformation. In our case we
have shown that the Ad-PNM-treated B13 cells can cure STZ-
induced diabetes. However, we have good evidence that the cells
are not glucose-responsive, so their curative ability must derive
from their constitutive insulin secretion. This is a reminder that
the ability to rescue experimental diabetes in rodents is not a very
discriminating characteristic. For treatment of human diabetes,
cells must have the exact glucose responsiveness of real beta cells
or they will not be signiﬁcantly better than the present regimes of
insulin injection. Whether beta cells are obtained by direct repro-
gramming or from other sources, such as directed differentiation
of pluripotent stem cells [41], it will be necessary to carefully
characterize the phenotype of the cells before proceeding.
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Reprogramming of pancreatic exocrine cells towards a beta cell character
using Pdx1, Ngn3 and MafA
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Figure S1 Location of the primer pairs used for ChIP, and CpGs sequenced for methylation analysis, in the genomic sequences of Pdx1, Ins1 and Ins2
Black, proximal promoter; blue, 5 untranslated region; red, ﬁrst exon. The sequences in parentheses indicate known regulatory elements. Primers for ChIP qPCR are highlighted in yellow. CGs
shown in bold type were sequenced in the DNA methylation assay.
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Table S1 Primer pairs used in RT–PCR, ChIP qPCR, DNA methylation analysis and qRT–PCR
Primer name Forward sequence (5–3) Reverse sequence (5–3)
Primers used in RT–PCR
Ins1 CTACAATCATAGACCATCAGCA CAGTTGGTAGAGGGAGCAGAT
Ins2 CCCTGTGGATCCGCTTCCTGC GTGCCAAGGTCTGAAGGTCA
Gcg GCTGGCAGCATGCCCCTCAA CCTTTGCTGCCTGGCCCTCC
Ppy CTATCCACTTGGGTGGCTCT ATCAAACCCACCAGAAGGC
Sst CCCAGACTCCGTCAGTTTCT GAAGTTCTTGCAGCCAGCTT
Iapp GGCTGTAGTTCCTGAAGCTT AAGGTTGTTGCTGGAGCGAA
Pax4 TGGAGAAAGAGTTCCAGCGT CTTGGGATGTGGTGTCACTG
Neurod1 TTTCAAACACGAACCATCCA CCTGTTTCTTCCAAAGGCAG
Nkx2.2 CACGCGCTCAAAGCCCAGGA GGAGAGAGCGGTGGGGCAGA
Arx AGGACGCCGAGGGCAAGGAT TCTCCCGCTTGCGCCACTTG
Pdx1 GTAGTAGCGGGACAACGAGC CAGTTGGGAGCCTGATTCTC
Ngn3 AAACTTCGAAGCGAGCAGAG CATCCTGAGGTTGGGAAAAA
MafA TCCAGGCTGGTGCGCGAAAG GCAAGCCCACTCAGGAGCCG
Isl1 TGATGCGCGCCCGCTCTAAG TGACTCGGGGACTGAGGCCG
Hlxb9 CCTGTCGCGACCCAAGCGTT CCCAGCAGCTCCTCCTCCGT
Pax6 GGCCGTGCGACATTTCCCGA GCCGTCTGCGCCCATCTGTT
Hes1 GGCCACCTGGCCAACTGCAT GCTGGAAGGCGACACTGCG
Glut2 GCCATCTTCCTCTTCGTCAG ACCTGGTTCCCTTCTGGTCT
Kir6.2 CTGGAAGGAAGCCAGTCTTG CAGTGTCCCCCAGACAAAGT
Sur1 AGCTGCGCTTCTGCCTCACG GGCACCCTGCTGGCTCTGTG
Amylase GCCTACTGACAGAGCCCTTG TGGTCCAATCCAGTCATTCA
Ptf1a CCTCTCCAAGGTAGACACGC CTTGGGATGTGGTGTCACTG
Cbe GACCGGCGGTACAGCTCGCG CTGCGCCCCACCGTGTAGAT
Pcsk2 ACACAGCTCCGCACATTCGCA TGAGATCCACAACCGCCCTCCA
Prss1 GTGTATCCTCCAACGATCTTGT CACTTCTGATCCTAGCCCTTG
Cpa1 CCAGAAGTCCAACTGCAAGT CAGTCTGTGGCAATGAGAACT
Ctrb1 GAATAGCATCCTCTCCGTTGAC GTCCTGCTTTGCCCTTGT
Rbpjl CATCTCCGAACCACACCTTG CTCCAGTGCCTCATATCAGC
Beta Actin TCCGTAAAGACCTCTATGCC GGAGGGGCCGGACTCATCGT
mNgn3 CCGGATGACGCCAAACTTACA ACACCAGTGCTCCCGGGAG
mPdx1 CCGGACATCTCCCCATACGAAGT CGCACAATCTTGCTCCGGCTCT
mMafA ATCATCACTCTGCCCACCAT AGTCGGATGACCTCCTCCTT
Primers used in ChIP qPCR
Ins1 CCAATGAGCGCTTTCTGCAGACTT AGGAGAGTACATACCTGCTTGCTG
Ins2 ACCAGGCAAGTGTTTGGAAACTGC ATGTAAGAGAAGAGCCCACAGCGT
Pdx1 AGAGATCAGCCTGCTGAGAGAGAA TACTGCTCCTCACTATTCATGGTGGC
Gapdh CTTTACGGGTGCACGTAGCTCA TTTCACCTGGCACTGCACAAGAAG
Primers used in DNA methylation assay
Ins1 1st set TTTTAGGTTTAAGTAGAGTTGTTGA CCCTAAAATTTTAACTAAAAAAACC
Ins1 2nd set GTTTTTTGTTTTTGTTGGTTTTGTT CACCCAACTCCAATTATAACACTTAC
Ins1 3rd set TTTTTGGGAGTTTAAGTTTGTTTAG ATACAACACTAATCCACAATACCAC
Ins2 1st set TTTGAGTTTTTTATTTGTTTTTTTT CTAATTTAATACTACCCTATTCCCC
Ins2 2nd set GATTATAAAGTTAGTGGGGATTTAGTAATT TATTTAACAAAAACCTAAACAAAAC
Ins2 3rd set GTATTTTTGTGGTTTTTATTTGGTG ACTTACCTTATAAATCCTCCACTTC
Pdx1 1st set AGGAGAGATTAGTTTGTTGAGAGAGAA AAAAACTACAAACCAAACCTTAAAC
Pdx1 2nd set ATTATGAATAGTGAGGAGTAGTATTA AAAAACTTCCCTATTCCAAC
Pdx1 3rd set GTTGGAATAGGGAAGTTTTT ACTTACCTACCCACTAACTTTTCCAC
Primers used in qPCR
Ins1 CAATCATAGACCATCAGCAAGC AGAAACCACGTTCCCCAC
Ins2 CCCAGGCTTTTGTCAAACAG GTGCCAAGGTCTGAAGGTC
Iapp CCACTGAAAGGGATCTTGAGAC TTCCGTTTGTCCACCTGAG
Pax4 GGGCAGTATCCAGATTCAGTTG GGCATCTGTGTTTCCCATTTC
Neurod1 ATGTCTTCCACGTCAAGCC GAGAAGTTGCCATTGATGCTG
Nkx2.2 GGTCAAGATCTGGTTCCAAAAC GTCACCTCCATACCTTTCTCAG
Arx AATCTAACCCATCCCCAACAC CTCTTCCTGGTACTGATTGCTC
Endogenous Pdx1 CCCGAGCTTCTGAAAACTTTG CTTTTCATTGTCCTCAGTTGGG
Endogenous Ngn3 TCCAGACGCAATTTACTCCAG CTAGTTCTCCGGGCTCAAAAG
Endogenous MafA TCTTTCTGTGAGCGCGG TCAGAGTCCGAACCGAGG
Isl1 TTGTTAGGGACGGGAAAACC CTACACAGCGGAAACATTCG
Hlxb9 GCTTTCCTACTCGTATCCTCAG TTCCCCAAGAGGTTCGATTG
Hes1 AGAAAAATTCCTCGTCCCCG TTTCATTTATTCTTGCCCGGC
Glut2 CACATCCTACTTGGCCTATCTG TCAGTGCCCCTTAGTCTTTTC
Kir6.2 TCAGTAAGCAATGAGCAGGG CAACCTCTGGACTGATATGCC
Sur1 AGAAGCTCCTAGAGTACACCG TGTAGGGAGTTGGAGATGGAG
Amylase GCAGACCTTTCATTTTCCAAGAG ACAAAACCCCAACCTTCTCC
Ptf1a AGGACCCCAGAAAACTCAAC CAATATGCACAAAGACACAGCC
Cbe ATGGTAATGAGGCGGTTGG AGGGCATGATATGGATTCGTG
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Table S1 Continued
Primer name Forward sequence (5–3) Reverse sequence (5–3)
Pcsk1 CTCAGCCCTTCCTACTTGTG CATTGACAAACTGCCTCTTCG
Pcsk2 GCATAAAGACGGAGAGGAAGAG TGGTAAAAGTGGTACAGGCC
Prss1 GTGTATCCTCCAACGATCTTGT CACTTCTGATCCTAGCCCTTG
Cpa1 CCAGAAGTCCAACTGCAAGT CAGTCTGTGGCAATGAGAACT
Cpb1 CACGTTGCTTATCAGTACCTCA GCCTCTCACTACAGTTGACTT
Ctrb1 GAATAGCATCCTCTCCGTTGAC GTCCTGCTTTGCCCTTGT
Rbpjl CATCTCCGAACCACACCTTG CTCCAGTGCCTCATATCAGC
Gapdh TCCAGTATGACTCTACCCACG CACGACATACTCAGCACCAG
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